Home Conference Coverage

Conference Coverage

Conference Coverage

Momentum Study: Oral Treatment Improves Care of Patients with Myelofibrosis

Peter Hofland, Ph.D - June 7, 2022

Panitumumab + mFOLFOX6 Significantly Improves OS in Patients with RAS wild-type mCRC

Omitting Radiotherapy after Breast Conserving Surgery in Low-Grade Luminal A Breast Cancer Patients

Biomarkers Predict Better Immunotherapy Treatment Outcomes for Patients with Pancreatic Cancer

Surgery Rather than Radiation Associated with Lower Stroke Risk in Head and Neck Cancer Patients

Encouraging Results for Cabozantinib Mono- and Combination Therapy Across Different Tumor...

Danielle Garcia - June 6, 2022

Oral Targeted Therapy Significantly Increases Overall Response Rate in Pediatric Low-Grade...

Editorial Team - June 6, 2022

Novel ADC Doubles Progression-Free Survival in Metastatic Breast Cancer with Low...

Danielle Garcia - June 6, 2022

Promising Activity with Zanidatamab In First-line Setting Of HER2+ Breast +...

Danielle Garcia - June 6, 2022

Annual Meeting of the American Society of Clinical Oncology at McCormick Place in Chicago, Ill.

Novel Drug Combination Demonstrates Promising Results in Treating Pancreatic Neuroendocrine Tumors

Peter Hofland, Ph.D - June 6, 2022

Ribociclib + Letrozole Maintained an OS benefit for Postmenopausal Patients with...

Peter Hofland, Ph.D - June 6, 2022

$Ongoing Studies with Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma$

Ongoing Studies with Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma

Editorial Team - June 6, 2022

Human kidney cross section. Photo courtesy: 2019 Fotolia

ASCO 2022: Racial Differences in Treatment and Outcomes of First-Line Therapies...

Danielle Garcia - June 5, 2022

Sacituzumab Govitecan Increases PFS for Patients With Most Common Type of...

Peter Hofland, Ph.D - June 5, 2022

Attendees networking during during the American Society of Clinical Oncology (ASCO) Annual Meeting. Courtesy: ? ASCO/Danny Morton

SORAYA Shows Consistent Safety Profile for Mirvetuximab Soravtansine in Ovarian Cancer

Danielle Garcia - June 5, 2022

12 3...44 Page 1 of 44

LATEST NEWS

Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth

Editorial Team - June 22, 2022

Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells

Editorial Team - June 21, 2022

Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...

Editorial Team - June 20, 2022

Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills

Michelle Andrews - June 14, 2022

Pioneering Novel Targeted Treatments in Lung Cancer

Editorial Team - June 10, 2022

Press Releases | Cancer

Mediaplanet Partners With Hematology Industry to Improve the... June 30, 2022
Mediaplanet’s Blood Health campaign, found within USA TODAY and online, unites organizations, experts, blood disorder and cancer patients, and families to raise awareness and educate the public about...(PRWeb June 30, 2022)Read the full story at https://www.prweb.com/releases/mediaplanet_partners_with_hematology_industry_to_improve_the_conversation_around_blood_health/prweb18766758.htm
HALO Diagnostics, IncellDx Partner to Advance Novel Testing, Improve... June 29, 2022
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.(PRWeb June 29, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18764263.htm
P-Cure to support Hadassah Medical Organization in being the first to... June 28, 2022
P-Cure Ltd., the provider of the most compact 360° gantry-less adaptive proton therapy system that can be installed in a linac vault, announced today a collaboration with Hadassah Medical...(PRWeb June 28, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18759722.htm